Hannover Rück SE (ETR:HNR1)
261.40
-5.00 (-1.88%)
Aug 1, 2025, 5:37 PM CET
CTI BioPharma Market Cap
Hannover Rück SE has a market cap or net worth of €31.52 billion as of August 1, 2025. Its market cap has increased by 13.55% in one year.
Market Cap
31.52B
Enterprise Value
35.90B
Revenue
27.72B
Ranking
n/a
PE Ratio
14.01
Stock Price
$261.40
Market Cap Chart
Since July 17, 1998, Hannover Rück SE's market cap has increased from 1.93B to 31.52B, an increase of 1,532.28%. That is a compound annual growth rate of 10.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 31.52B | 8.29% |
Dec 30, 2024 | 29.11B | 11.60% |
Dec 29, 2023 | 26.09B | 16.60% |
Dec 30, 2022 | 22.37B | 10.98% |
Dec 30, 2021 | 20.16B | 28.28% |
Dec 30, 2020 | 15.71B | -24.38% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Allianz SE | 131.98B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.19B |
Deutsche Bank Aktiengesellschaft | 55.92B |
Deutsche Börse AG | 46.31B |
Commerzbank AG | 37.38B |
Talanx AG | 29.81B |
DWS Group GmbH & Co. KGaA | 10.54B |
flatexDEGIRO AG | 2.86B |